Acceso abierto

Testing of mechanisms of action of rituximab and clinical results in high-risk patients with aggressive CD20+ lymphoma


Cite

Barbara Novaković
Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Vladimir Kotnik
Institute of Microbiology and Immunology, Medical Faculty Ljubljana, Ljubljana, Slovenia
Tanja Šetina
Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Marjeta Vovk
Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Srdjan Novaković
Department of Molecular Diagnostics, Institute of Oncology Ljubljana, Ljubljana, Slovenia
eISSN:
1581-3207
ISSN:
1318-2099
Idioma:
Inglés
Calendario de la edición:
4 veces al año
Temas de la revista:
Medicine, Clinical Medicine, Radiology, Internal Medicine, Haematology, Oncology